Doorgaan naar hoofdnavigatie
Doorgaan naar zoeken
Ga verder naar hoofdinhoud
Sorteer per
Keyphrases
Clinical Outcomes
100%
Transplantation
100%
Newly Diagnosed
100%
Philadelphia Chromosome-positive Acute Lymphoblastic Leukemia
100%
Unrelated Donor
83%
Acute Lymphoblastic Leukemia
66%
Ph-positive
66%
Chemotherapy Alone
50%
Chemotherapy
33%
Leukocyte Count
33%
Late Relapse
16%
Overall Survival Rate
16%
Event-free Survival
16%
Hematopoietic Stem Cell Transplantation
16%
Hazard Ratio
16%
Complete Remission
16%
Tyrosine Kinase Inhibitor
16%
Early Treatment
16%
Treatment Outcome
16%
Philadelphia Chromosome
16%
Early Response
16%
Multivariate Cox Regression Analysis
16%
First Remission
16%
Prognostic Indicator
16%
Follow-up Interval
16%
Disease Control
16%
HLA-matched Donor
16%
Therapeutic Impact
16%
Tyrosine Kinase Inhibitor Therapy
16%
Count Response
16%
Historical References
16%
Nursing and Health Professions
Acute Lymphoblastic Leukemia
100%
Clinical Outcome
100%
Philadelphia 1 Chromosome
100%
Remission
40%
Leukocyte Count
40%
Protein Tyrosine Kinase Inhibitor
40%
Adolescent
20%
Survival Rate
20%
Hematopoietic Stem Cell Transplantation
20%
Overall Survival
20%
Hazard Ratio
20%
Event Free Survival
20%
Proportional Hazards Model
20%
Treatment Outcome
20%
Treatment Response
20%
Disease Control
20%
Medicine and Dentistry
Acute Lymphoblastic Leukemia
100%
Philadelphia 1 Chromosome
100%
Chemotherapy
100%
Tyrosine-Kinase Inhibitor
40%
Leukocyte
40%
Disease
20%
Proportional Hazards Model
20%
Treatment Response
20%
Event Free Survival
20%
Survival Rate
20%
Overall Survival
20%
Hazard Ratio
20%
Hematopoietic Stem Cell Transplantation
20%
Adolescence
20%
Pharmacology, Toxicology and Pharmaceutical Science
Chemotherapy
100%
Acute Lymphoblastic Leukemia
100%
Philadelphia 1 Chromosome
100%
Remission
40%
Protein Tyrosine Kinase Inhibitor
40%
Disease
20%
Event Free Survival
20%
Overall Survival
20%
Survival Rate
20%
Immunology and Microbiology
Leukocyte Count
100%
Philadelphia 1 Chromosome
100%
Hematopoietic Stem Cell Transplantation
50%
Survival Rate
50%
Overall Survival
50%
Event Free Survival
50%
Adolescence
50%
Neuroscience
Leukocyte
100%
Philadelphia 1 Chromosome
100%
Tyrosine Kinase Inhibitor
100%
Hematopoietic Cell
50%